Insider Transactions in Q2 2023 at Cytom X Therapeutics, Inc. (CTMX)

CTMX Quotes by TradingView

Insider Transaction List (Q2 2023)

Date Insider Transaction Ownership Type Shares Traded Value / Price
May 19 2023
Sean A. Mc Carthy CEO
BUY
Exercise of conversion of derivative security
Direct
16,535 +3.92%
$16,535 $1.57 P/Share

Track Institutional and Insider Activities on CTMX

Follow CytomX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTMX shares.

Notify only if

Insider Trading

Get notified when an Cytom X Therapeutics, Inc. insider buys or sells CTMX shares.

Notify only if

News

Receive news related to CytomX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTMX